Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Knowledge of genomic testing among early-stage breast cancer patients.

Psycho-oncology - 1 Jan 2011

Richman Alice R, Tzeng Janice P, Carey Lisa A, Retèl Valesca P, Brewer Noel T

Abstract excerpt

BACKGROUND: Genomic recurrence risk test results now inform clinical decisions about adjuvant treatment for women with early-stage breast cancer. We sought to understand patients' knowledge of these tests and correlates of their knowledge. METHODS: Participants in this cross-sectional study were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to Cross-Sectional Studies
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Health Knowledge, Attitudes, Practice

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Recurrence

Source

Identifiers

PMID: 20200857
DOI: 10.1002/pon.1699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20200857-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Knowledge of genomic testing among early-stage breast cancer patients.PMID 20200857Read ↗

Impact of genomic testing and patient-reported outcomes on receipt of adjuvant chemotherapy.Semantic proximity Read ↗

Health literacy and cancer risk perception: implications for genomic risk communication.Semantic proximity Read ↗

Patterns of 21-gene assay testing and chemotherapy use in black and white breast cancer patients.Semantic proximity Read ↗

IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancerSemantic proximity Read ↗

Genetic cancer risk knowledge among Mexican pathogenic variant carriers.Semantic proximity Read ↗

Metastatic breast cancer patient perceptions of somatic tumor genomic testing.Semantic proximity Read ↗

Factors Associated With Inaccurate Recall of Inherited Cancer Genetic Test Results Among Individuals With Germline Pathogenic Variants.Semantic proximity Read ↗

Metastatic breast cancer patient perception of somatic tumor genomic testingSemantic proximity Read ↗

Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge ItemsSemantic proximity Read ↗

Metastatic breast cancer patient perception of somatic tumor genomic testingSemantic proximity Read ↗

The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.Semantic proximity Read ↗

Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.